CompuMed, Inc. (CMPD)
USD 3.0
(-16.67%)
USD 3.0
(-16.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -686.23 Thousand USD | 45.56% |
| 2022 | -1.26 Million USD | 12.93% |
| 2021 | -1.44 Million USD | -81.93% |
| 2020 | -795.74 Thousand USD | -17.75% |
| 2019 | -675.79 Thousand USD | -165.91% |
| 2018 | -254.14 Thousand USD | -23.55% |
| 2017 | -205.7 Thousand USD | -135.24% |
| 2016 | -87.44 Thousand USD | 0.0% |
| 2011 | 140 Thousand USD | 94.44% |
| 2010 | 72 Thousand USD | -11.11% |
| 2009 | 81 Thousand USD | 190.0% |
| 2008 | -90 Thousand USD | 88.2% |
| 2007 | -763 Thousand USD | -2284.38% |
| 2006 | -32 Thousand USD | 73.77% |
| 2005 | -122 Thousand USD | -713.33% |
| 2004 | -15 Thousand USD | 74.58% |
| 2003 | -59 Thousand USD | 6.35% |
| 2002 | -63 Thousand USD | 64.41% |
| 2001 | -177 Thousand USD | -390.16% |
| 2000 | 61 Thousand USD | 102.77% |
| 1999 | -2.2 Million USD | -2300.0% |
| 1998 | 100 Thousand USD | -50.0% |
| 1997 | 200 Thousand USD | 300.0% |
| 1996 | -100 Thousand USD | -102.94% |
| 1995 | 3.4 Million USD | -10.53% |
| 1994 | 3.8 Million USD | 660.0% |
| 1993 | 500 Thousand USD | 183.33% |
| 1992 | -600 Thousand USD | 14.29% |
| 1991 | -700 Thousand USD | -450.0% |
| 1990 | 200 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -519.92 Thousand USD | 24.23% |
| 2024 Q3 | -966.1 Thousand USD | -41.79% |
| 2024 Q2 | -681.35 Thousand USD | -31.05% |
| 2023 Q3 | -739.03 Thousand USD | 30.85% |
| 2023 Q2 | -1.06 Million USD | -3.49% |
| 2023 Q1 | -1.03 Million USD | 18.07% |
| 2023 FY | -686.23 Thousand USD | 45.56% |
| 2023 Q4 | -686.23 Thousand USD | 7.15% |
| 2022 Q2 | -1.03 Million USD | 11.65% |
| 2022 Q4 | -1.26 Million USD | -23.14% |
| 2022 Q1 | -1.16 Million USD | 19.29% |
| 2022 FY | -1.26 Million USD | 12.93% |
| 2022 Q3 | -1.02 Million USD | 0.84% |
| 2021 Q2 | -822.67 Thousand USD | 0.0% |
| 2021 Q4 | -1.44 Million USD | -21.78% |
| 2021 Q3 | -1.18 Million USD | -44.5% |
| 2021 FY | -1.44 Million USD | -81.93% |
| 2020 FY | -795.74 Thousand USD | -17.75% |
| 2019 FY | -675.79 Thousand USD | -165.91% |
| 2018 FY | -254.14 Thousand USD | -23.55% |
| 2017 FY | -205.7 Thousand USD | -135.24% |
| 2016 FY | -87.44 Thousand USD | 0.0% |
| 2011 Q3 | 314 Thousand USD | 685.0% |
| 2011 Q4 | 140 Thousand USD | -55.41% |
| 2011 FY | 140 Thousand USD | 94.44% |
| 2011 Q1 | 136 Thousand USD | 88.89% |
| 2011 Q2 | 40 Thousand USD | -70.59% |
| 2010 Q3 | 35 Thousand USD | 147.3% |
| 2010 Q1 | 69 Thousand USD | -14.81% |
| 2010 Q2 | -74 Thousand USD | -207.25% |
| 2010 Q4 | 72 Thousand USD | 105.71% |
| 2010 FY | 72 Thousand USD | -11.11% |
| 2009 Q3 | 56 Thousand USD | 64.71% |
| 2009 FY | 81 Thousand USD | 190.0% |
| 2009 Q1 | 130 Thousand USD | 244.44% |
| 2009 Q4 | 81 Thousand USD | 44.64% |
| 2009 Q2 | 34 Thousand USD | -73.85% |
| 2008 Q3 | -87 Thousand USD | -70.59% |
| 2008 Q1 | -201 Thousand USD | 73.66% |
| 2008 Q2 | -51 Thousand USD | 74.63% |
| 2008 Q4 | -90 Thousand USD | -3.45% |
| 2008 FY | -90 Thousand USD | 88.2% |
| 2007 FY | -763 Thousand USD | -2284.38% |
| 2007 Q4 | -763 Thousand USD | 27.75% |
| 2007 Q1 | 143 Thousand USD | 546.88% |
| 2007 Q3 | -1.05 Million USD | 41.79% |
| 2007 Q2 | -1.81 Million USD | -1368.53% |
| 2006 Q1 | 6000.00 USD | 104.92% |
| 2006 Q4 | -32 Thousand USD | 52.94% |
| 2006 Q2 | -177 Thousand USD | -3050.0% |
| 2006 Q3 | -68 Thousand USD | 61.58% |
| 2006 FY | -32 Thousand USD | 73.77% |
| 2005 Q3 | 26 Thousand USD | 213.04% |
| 2005 FY | -122 Thousand USD | -713.33% |
| 2005 Q4 | -122 Thousand USD | -569.23% |
| 2005 Q2 | -23 Thousand USD | 61.67% |
| 2005 Q1 | -60 Thousand USD | -300.0% |
| 2004 Q4 | -15 Thousand USD | 83.15% |
| 2004 Q3 | -89 Thousand USD | -154.29% |
| 2004 FY | -15 Thousand USD | 74.58% |
| 2004 Q1 | -26 Thousand USD | 55.93% |
| 2004 Q2 | -35 Thousand USD | -34.62% |
| 2003 Q1 | -62 Thousand USD | 1.59% |
| 2003 Q2 | -14 Thousand USD | 77.42% |
| 2003 Q4 | -59 Thousand USD | -145.83% |
| 2003 FY | -59 Thousand USD | 6.35% |
| 2003 Q3 | -24 Thousand USD | -71.43% |
| 2002 Q2 | -91 Thousand USD | 18.75% |
| 2002 Q4 | -63 Thousand USD | -12.5% |
| 2002 FY | -63 Thousand USD | 64.41% |
| 2002 Q1 | -112 Thousand USD | 36.72% |
| 2002 Q3 | -56 Thousand USD | 38.46% |
| 2001 Q4 | -177 Thousand USD | 18.06% |
| 2001 Q2 | -129 Thousand USD | 3.73% |
| 2001 Q3 | -216 Thousand USD | -67.44% |
| 2001 Q1 | -134 Thousand USD | -319.67% |
| 2001 FY | -177 Thousand USD | -390.16% |
| 2000 Q3 | -267 Thousand USD | 29.55% |
| 2000 FY | 61 Thousand USD | 102.77% |
| 2000 Q4 | 61 Thousand USD | 122.85% |
| 2000 Q2 | -379 Thousand USD | 68.42% |
| 2000 Q1 | -1.2 Million USD | 45.45% |
| 1999 Q3 | - USD | -100.0% |
| 1999 Q4 | -2.2 Million USD | 0.0% |
| 1999 FY | -2.2 Million USD | -2300.0% |
| 1999 Q2 | 300 Thousand USD | 50.0% |
| 1999 Q1 | 200 Thousand USD | 100.0% |
| 1998 Q4 | 100 Thousand USD | -50.0% |
| 1998 FY | 100 Thousand USD | -50.0% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q2 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1997 Q1 | - USD | 100.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | 200 Thousand USD | 0.0% |
| 1997 FY | 200 Thousand USD | 300.0% |
| 1996 Q1 | 3.8 Million USD | 11.76% |
| 1996 Q4 | -100 Thousand USD | 0.0% |
| 1996 Q3 | -100 Thousand USD | -102.7% |
| 1996 Q2 | 3.7 Million USD | -2.63% |
| 1996 FY | -100 Thousand USD | -102.94% |
| 1995 Q2 | 3.5 Million USD | 0.0% |
| 1995 FY | 3.4 Million USD | -10.53% |
| 1995 Q4 | 3.4 Million USD | 0.0% |
| 1995 Q3 | 3.4 Million USD | -2.86% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q1 | 500 Thousand USD | 0.0% |
| 1994 FY | 3.8 Million USD | 660.0% |
| 1994 Q4 | 3.8 Million USD | 0.0% |
| 1993 Q4 | 500 Thousand USD | 66.67% |
| 1993 Q3 | 300 Thousand USD | 0.0% |
| 1993 FY | 500 Thousand USD | 183.33% |
| 1992 Q2 | -200 Thousand USD | 0.0% |
| 1992 Q4 | -600 Thousand USD | 0.0% |
| 1992 FY | -600 Thousand USD | 14.29% |
| 1991 Q1 | - USD | -100.0% |
| 1991 Q4 | -700 Thousand USD | 0.0% |
| 1991 FY | -700 Thousand USD | -450.0% |
| 1990 FY | 200 Thousand USD | 0.0% |
| 1990 Q4 | 200 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Achiko AG | 2.48 Million USD | 127.572% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 3.95 Million USD | 117.366% |
| Cannabis Sativa, Inc. | 206.45 Thousand USD | 432.383% |
| CompuGroup Medical SE & Co. KGaA | 775.35 Million USD | 100.089% |
| Cogstate Limited | -29.45 Million USD | 97.67% |
| CareView Communications, Inc. | 19.88 Million USD | 103.452% |
| Craneware plc | 783 Thousand USD | 187.641% |
| Caduceus Software Systems Corp. | 2.38 Million USD | 128.736% |
| Certive Solutions Inc. | 5.68 Million USD | 112.075% |
| Drug Free Solution, Inc. | -12.5 Thousand USD | -5388.97% |
| DATATRAK International, Inc. | 103.82 Thousand USD | 760.943% |
| Strainsforpains, Inc. | 1.93 Million USD | 135.529% |
| Healixa Inc. | 6.5 Million USD | 110.551% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | -668.66 Thousand USD | -2.626% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | 459.64 Thousand USD | 249.296% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | 5062.82 USD | 13654.323% |
| IQ-AI Limited | -176.63 Thousand USD | -288.513% |
| Cannabiz Mobile, Inc. | 494.04 Thousand USD | 238.901% |
| Mednow Inc. | 2.11 Million USD | 132.379% |
| Galileo Life Sciences, Inc. | 17.02 Thousand USD | 4130.962% |
| MediXall Group, Inc. | 2.81 Million USD | 124.356% |
| Mitesco, Inc. | 1.76 Million USD | 138.905% |
| MobileSmith, Inc. | 4.85 Million USD | 114.13% |
| NantHealth, Inc. | 265.64 Million USD | 100.258% |
| Net Medical Xpress Solutions, Inc. | 661 Thousand USD | 203.817% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | 8.48 Million USD | 108.088% |
| Patient Access Solutions, Inc. | 910.34 Thousand USD | 175.381% |
| Pharma-Bio Serv, Inc. | -10.09 Million USD | 93.205% |
| PPJ Healthcare Enterprises, Inc. | 2.54 Million USD | 126.975% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 180.002% |
| Renalytix Plc | 3.85 Million USD | 117.801% |
| Revium Recovery Inc. | -529 Thousand USD | -29.722% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -414.83 Thousand USD | -65.424% |
| Vaso Corporation | -9.28 Million USD | 92.607% |
| Vynleads, Inc. | 513.29 Thousand USD | 233.692% |